Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyJens G. Lohr, Keith Stockerl-Goldstein, Michael S. Lawrence et al.|Cancer Cell|2014Cited by 1k
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with<sup>131</sup>I-tositumomabRebecca Elstrom, Mark Kaminski, Jia Ruan et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 14